Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Luteolin is a rare substrate of human catechol-O-methyltransferase favoring a para-methylation.

Chen ZJ, Dai YQ, Kong SS, Song FF, Li LP, Ye JF, Wang RW, Zeng S, Zhou H, Jiang HD.

Mol Nutr Food Res. 2013 May;57(5):877-85. doi: 10.1002/mnfr.201200584.

PMID:
23386290
2.

Computational studies of the regioselectivities of COMT-catalyzed meta-/para-O methylations of luteolin and quercetin.

Cao Y, Chen ZJ, Jiang HD, Chen JZ.

J Phys Chem B. 2014 Jan 16;118(2):470-81. doi: 10.1021/jp410296s.

PMID:
24354565
3.

Role of catechol-O-methyltransferase in the disposition of luteolin in rats.

Chen Z, Chen M, Pan H, Sun S, Li L, Zeng S, Jiang H.

Drug Metab Dispos. 2011 Apr;39(4):667-74. doi: 10.1124/dmd.110.037333.

4.

Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.

Palma PN, Bonifácio MJ, Loureiro AI, Wright LC, Learmonth DA, Soares-da-Silva P.

Drug Metab Dispos. 2003 Mar;31(3):250-8.

6.
8.

O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.

Zhu BT, Patel UK, Cai MX, Conney AH.

Drug Metab Dispos. 2000 Sep;28(9):1024-30.

9.

Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.

Quintieri L, Palatini P, Nassi A, Ruzza P, Floreani M.

Biochem Pharmacol. 2008 Mar 15;75(6):1426-37. doi: 10.1016/j.bcp.2007.11.012.

PMID:
18191104
10.

Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.

Goodman JE, Jensen LT, He P, Yager JD.

Pharmacogenetics. 2002 Oct;12(7):517-28.

PMID:
12360102
12.

The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.

Gallagher EP, Kunze KL, Stapleton PL, Eaton DL.

Toxicol Appl Pharmacol. 1996 Dec;141(2):595-606.

PMID:
8975785
13.

Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.

Malherbe P, Bertocci B, Caspers P, Zürcher G, Da Prada M.

J Neurochem. 1992 May;58(5):1782-9.

PMID:
1560233
14.

Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate.

Zhu BT, Shim JY, Nagai M, Bai HW.

Xenobiotica. 2008 Feb;38(2):130-46. doi: 10.1080/00498250701744641 .

PMID:
18197555
18.
19.

Catechol-O-methyltransferase from rat liver: two forms having different meta:para methylation ratios.

Marzullo G, Friedhoff AJ.

Life Sci. 1975 Sep 15;17(6):933-41. No abstract available.

PMID:
570
20.

Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.

Palma PN, Rodrigues ML, Archer M, Bonifácio MJ, Loureiro AI, Learmonth DA, Carrondo MA, Soares-da-Silva P.

Mol Pharmacol. 2006 Jul;70(1):143-53.

Items per page

Supplemental Content

Support Center